Author response: Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
Leen Farhat-Younis(Tel Aviv University), Yaron Carmi(Tel Aviv University)
Cited by 0
Related Papers
Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy
|eLife|2022|52
Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity
|JCI Insight|2016|27
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
|eLife|2023|3
Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0